Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 5, 2006, Pages 940-951

  Epstein, Murray ^a   Williams, Gordon H ^a   Weinberger, Myron ^a   Lewin, Andrew ^a   Krause, Scott ^a   Mukherjee, Robin ^a   Patni, Rajiv ^a   Beckerman, Bruce ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; ENALAPRIL; EPLERENONE; POTASSIUM; SPIRONOLACTONE;

AGED; ALBUMINURIA; ARTICLE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

AGED; ALBUMINURIA; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERKALEMIA; INCIDENCE; MALE; MIDDLE AGED; POTASSIUM; SPIRONOLACTONE; TREATMENT OUTCOME; UNITED STATES;

EID: 33750331264     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00240106     Document Type: Article

References (0)